Venu Holding Corp director holds 250K-share option
The option’s vesting is divided between July 10, 2026, and July 10, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Venu Holding Corp director Ronald Bension reported a directly held stock option covering 250,000 common shares, with an exercise price of $2.9100 per share and an expiration date of July 10, 2034. The board approved the option. Of the underlying shares, 125,000 vested and became exercisable on July 10, 2026; the remaining 125,000 are scheduled to vest and become exercisable on July 10, 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1, F2 | -- | -- | -- |
Footnotes (2)
- F1. This option was approved by the board of directors of Venu Holding Corporation (the "Issuer") and is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d)(1) promulgated thereunder.
- F2. This option vested and became exercisable with respect to 125,000 shares of the Issuer's common stock on July 10, 2026, the grant date, and will vest and become exercisable with respect to the remaining 125,000 shares on July 10, 2027.
Key Figures
Key Terms
Stock Option (Right to Buy) technical
vested and became exercisable technical
Rule 16b-3(d)(1) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.